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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYEpidermal stem cells have been in clinical application as a source of culture-generated grafts. Although applications for such cells are
increasing due to aging populations and the greater incidence of diabetes, current keratinocyte grafting technology is limited by immu-
nological barriers and the time needed for culture amplification. We studied the feasibility of using human fetal skin cells for allogeneic
transplantation and showed that fetal keratinocytes have faster expansion times, longer telomeres, lower immunogenicity indicators,
and greater clonogenicity with more stem cell indicators than adult keratinocytes. The fetal cells did not induce proliferation of
T cells in coculture and were able to suppress the proliferation of stimulated T cells. Nevertheless, fetal keratinocytes could stratify
normally in vitro. Experimental transplantation of fetal keratinocytes in vivo seeded on an engineered plasma scaffold yielded a well-
stratified epidermal architecture and showed stable skin regeneration. These results support the possibility of using fetal skin cells for
cell-based therapeutic grafting.INTRODUCTION
The grafting of cultured keratinocytes to promote regener-
ation represents one of the oldest clinical examples of stem
cell therapy (Green, 2008). The skin constitutes an essential
barrier between the living tissues of the body and the
external environment, and skin tissues have evolved to
maintain that barrier: water is retained and noxious sub-
stances and invasive organisms are excluded, and new
skin normally can be regenerated rapidly in the event of a
break in this barrier. However, large interruptions in the
skin are life threatening: burns can result in deep, extensive
wounds that are slow to close without medical interven-
tion. The gold-standard treatment for large wounds is
autologous split-skin grafts, but this is not possible for
extensive full- or partial-thickness burns covering over
50% of the body surface area. In addition to acute skin
injuries, chronic wounds are now a growing medical chal-
lenge as nonhealing wounds become more common in
aging populations of the developed world, and increase
further with rising rates of diabetes and resulting circula-
tory deficiencies. Large wounds are usually grafted with
cadaveric skin (if available) to form a temporary barrier
until the allogeneic cells are immunologically rejected.
Alternatively, cultured epithelial autografts can be used
for covering such wounds. The patient’s own epidermal
cells are isolated, expanded in the laboratory, and used to
replace the damaged skin (Green et al., 1979; Compton324 Stem Cell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Autet al., 1989) without any tissue rejection. The major disad-
vantage of this approach is that it takes at least 3 weeks to
grow enough cells for successful grafting, due to the low
number of keratinocyte stem cells recovered from skin
biopsies.
Much work has also been directed toward developing
bioengineered skin substitutes using cultured cells (kerati-
nocytes and/or fibroblasts) with a suitable matrix (Pham
et al., 2007), but the difficulty of achieving permanent
wound coverage for patients with large or intransigent
wounds persists (Turk et al., 2014; Kamel et al., 2013). Bio-
engineered products have been hampered by immune
rejection, vascularization problems, difficulty of handling,
and failure to integrate due to scarring and fibrosis. Further-
more, no currently available bioengineered skin replace-
ment can fully replace the anatomical and functional
properties of the native skin, and appendage development
is absent in the healed area of full-thickness culture-grafted
wounds.
Thus, alternative sources of cells for engineering skin
substitutes are urgently required to address this area of
clinical need. One possibility is to use fetal skin as a po-
tential cell source for tissue-engineered skin. Several types
of fetal cells have been shown to have higher prolife-
rative capacities and to be less immunogenic than their
adult counterparts, suggesting potential allogeneic appli-
cations (Guillot et al., 2007; Davies et al., 2009; Montjo-
vent et al., 2009; Go¨therstro¨m et al., 2004; Zhang et al.,hors
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developmental continuum, fetal cells offer several advan-
tages as cell sources for therapeutic applications. Fetal
cells are likely to harbor fewer of the mutations that accu-
mulate over the lifetime of an organism, and may also
possess greater proliferative potential and plasticity than
adult stem cells. Although all stem cells are self-renewing
and multipotent by definition, it is believed that stem
cells from younger donors should have greater potential
(Van Zant and Liang, 2003; Roobrouck et al., 2008). In
addition, fetal cells may possess immunomodulatory
properties associated with the fetal/maternal interface
(Gaunt and Ramin, 2001; Kanellopoulos-Langevin et al.,
2003). The use of early or midtrimester fetal tissue for
skin tissue engineering was first suggested by Hohlfeld
et al. (2005), who developed dermal-mimetic constructs
using fetal dermal fibroblasts. Although their technique
was reported to promote healing of severe burns, engraft-
ment was only temporary and did not provide perma-
nent cover.
Here, we demonstrate that second-trimester fetal kerati-
nocytes can be isolated and expanded in a robust and stable
manner under conditions in which they maintain genetic
stability and high proliferative potential. We also show
that fetal keratinocytes are capable of differentiating in
organotypical cultures and can fully differentiate upon
grafting. Together with the fact that these cells show low
expression of major histocompatibility complex (MHC)
proteins, these findings suggest that these cells have sig-
nificant potential as an allogeneic source of skin cells for
life-saving culture-generated grafts.RESULTS
Histological Differences between Adult and Fetal Skin
To understand the developmental state in situ of the fetal
skin from which cells were being cultured, we analyzed
fetal dorsal trunk skin histologically at various second-
trimester gestational ages (13–22 weeks gestation) and
compared it with adult skin. We analyzed keratin expres-
sion during development by immunofluorescence using a
panel of well-characterizedmonospecificmonoclonal anti-
bodies to keratins. Expression of keratin 14 (K14, a marker
for basal keratinocytes [Fuchs and Green, 1980]) and K15
(which is enriched in stable basal cells [Porter et al., 2000]
and some epidermal stem cell niches [Lyle et al., 1998])
was similar in fetal and adult skin (Figure 1A; Figure S1B
available online). In contrast, expression of K18, K17, and
K19 was seen in the basal layer of fetal epidermis, but not
in adult interfollicular epidermal keratinocytes. In adult
skin, K18, K17, and K19 are associated with appendages,
stress responses, and stem cell compartments (Lane et al.,Stem C1991; Michel et al., 1996). Results from further staining
with othermarkers are summarized in Table S1 (see also Fig-
ures S1–S3).
Culture and Characterization of Human Fetal
Keratinocytes
We developed a robust method for culturing fetal keratino-
cytes from skin at 15–22 weeks gestation. Samples from
<15 weeks gestation were very small and cells isolated
before 18 weeks were poorly adherent, so it was necessary
to coat the culture flasks with 0.1% gelatin to achieve
adequate cell attachment. Fibroblast contamination was
not significant because fibroblasts were easily removed
from first-passage cultures by 5 min incubation in
0.02% EDTA; no fibroblasts were observed at subsequent
passages (Figure S4). In serum-free culture conditions,
fetal keratinocytes exhibited a typical cobblestone epithe-
lial pattern of growth, but were noticeably smaller than
their adult counterparts (diameter: fetal = 16.7 ± 0.1 mm,
adult = 20.8 ± 0.6 mm, p < 0.01; volume: fetal = 2.4 ±
0.03 pL, adult = 4.7 ± 0.4 pL, p < 0.01; n = 3 adult and 3 fetal
samples; Figures S4F–S4G).
K14 and K7 were uniformly expressed in fetal keratino-
cyte cultures, whereas K18 and K19 were positive in
94.4% ± 4.0% and 14.6% ± 4.8% of cells in the cultures,
respectively (n = 4), revealing a heterogeneous population
of keratinocytes (Figure 1B). In contrast, adult keratino-
cytes did not express either K18 or K19, and only aminority
of cells (6.5% ± 6.7%) expressed K7.
When we tested the cultures for expression of keratino-
cyte stem/progenitor markers, we observed expression
of MTS24 as previously reported (Nijhof et al., 2006;
Depreter et al., 2008) in clusters, with more clusters
found in fetal cultures (17 and 22 weeks gestation) than
in adult cultures (n = 2; Figure 1C). Delta-like-1 (DLL1)
(Tan et al., 2013; Lowell et al., 2000) was expressed
in both fetal and adult keratinocytes, although the
staining was subjectively observed to be much stronger
in fetal cells than in adult cells under the same culture
conditions (Figure 1D). Other stem cell-associated markers
(MCSP, NFATc1, and Thy-1) were also tested, and gave
staining in all cells in the culture, with no significant
differences between adult and fetal keratinocytes (data
not shown).
To establish the stability of the fetal cells, the karyotype
of fetal cultures at passage 3 to passage 7 was examined
and observed to be normal (i.e., 46 XX or 46 XY), showing
no gross karyotypic abnormalities as determined by G-
banding (Figure 2A). Fetal keratinocytes also showed
reproducibly high recovery rates (82% ± 9%) after 3 years
of storage in liquid nitrogen following cryopreservation
via a gradual freezing method in a routine lab setting
(Figure 2B).ell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Authors 325
Figure 1. Characterization of Fetal Skin
(A) Immunofluorescence staining of kera-
tins in fetal (18 weeks) and adult epidermis.
K18, K17, and K19 were present in fetal
epidermis, but not in adult epidermis
(except for adult hair follicles, which show
expression of K19 [inset]). Scale bar,
100 mm. See also Figures S1–S3 for a full
range of images.
(B) Expression of K14, K18, and K19
in cultured fetal keratinocytes isolated from
dorsal skin (17 weeks) at passage 4 and
adult keratinocytes grown to 90% con-
fluence. Fetal keratinocytes show higher
expression of K18 and K19, consistent with
the expression in in vivo tissue sections.
(C) Expression of MTS24 in fetal (17 and
22 weeks) and adult keratinocytes.
(D) Expression of Delta-like 1 (DLL1) in fetal
and adult keratinocytes. Images in the
micrographs were taken with the same
exposure time. Scale bar, 100 mm. See also
Figure S4 for further results for cultured
cells.
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Potential than Adult Keratinocytes
Two independent lines of evidence indicate that fetal
keratinocytes have higher proliferation potential than
adult keratinocytes. First, in tissue sections, immunohis-
tochemical staining with the nuclear cell proliferation
marker Ki67 showed the highest proportion of Ki67-
positive cells in the youngest samples tested, with a
decreasing trend in the proliferation index (PI) with
increasing sample age (Figure 3A). Second, in parallel,326 Stem Cell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Autcultured fetal keratinocytes reached a higher cumulative
population doubling (pd) before senescence than adult
cells (20 pd [fetal] versus 12 pd [adult] by 40 days of cul-
ture: Figure 3B). Two adult and four fetal skin samples
were assayed with five technical replicates each. Typical
pd times for fetal keratinocytes (14–22 weeks) were 30.3
± 7.5 hr compared with 49.3 ± 8.4 hr for adult keratino-
cytes (p < 0.0001; Figures 3C and S5). Telomere lengths
were longer in fetal keratinocytes (14 and 19 weeks
gestation) than in adult keratinocytes, and shortened byhors
Figure 2. Karyotyping Analysis and Re-
covery of Cryopreserved Fetal Keratino-
cytes
(A) Fetal keratinocytes maintain a normal
karyotype after serial passaging. Karyotype
analysis by G-banding is represented here
by 22-week fetal keratinocytes. The chro-
mosome complement remained normal as
far as P7.
(B) Fetal keratinocytes cryopreserved in
low-serum-containingmedium (70% serum-
free medium/20% FBS/10% DMSO) show
reproducibly high recovery after thawing.
Percentage recovery is defined as the
percentage of frozen cells that remained
viable after thawing. Fetal keratinocytes
(15, 16, 17, and 22 weeks) at P2 were
recovered 2–3.5 years after cryopreser-
vation. Recovery is comparable to that
observed for adult keratinocytes recovered
after 1.5–2 years. Data are represented as
mean ± SD of n biological replicates.
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Fetal Keratinocytes for Skin Reconstruction7.6% over two passages in fetal cultures and 8.9% in adult
cultures (Figure 3D).
We further evaluated the self-renewal capacity of these
keratinocytes by performing colony-forming efficiency
(CFE) assays (Barrandon and Green, 1985). Fetal keratino-
cytes had a 9.8-fold higher CFE than adult keratinocytes
at low passage (30.3% versus 3.1%, p < 0.001). Although
the CFE for both fetal and adult keratinocytes was reduced
with increasing passages, the fetal keratinocytes main-
tained a superior clonogenic ability compared with their
adult counterparts (Figure 3E). High clonogenic potential
is widely regarded as a characteristic of stem or progenitor
cells.
Fetal Keratinocytes Express Lower MHC Antigen
Levels than Adult Keratinocytes
Both MHC I and MHC II antigens were weakly detected
in fetal skin, with some positive cells in the dermis and
hair germs in the epidermis, but most of the epidermis
was negative for MHC I (Figure 4A). Expression of MHC I
increased with increasing gestational age and was ex-Stem Cpressed ubiquitously in adult skin. Expression of MHC II
in fetal skin was scattered, with sporadic positive cells
in the dermis and epidermis, possibly due to the presence
of Langerhans cells and other antigen-presenting cells
that express MHC II. MHC II expression was higher in
adult skin than in fetal skin, but was similarly scattered.
MHC I expression in fetal keratinocytes was low, with
5% expression at 16 weeks, but increased to 19% by
22 weeks. More than a third of adult keratinocytes were
positive for MHC I. MHC II was similarly expressed in
<5% of both fetal and adult keratinocytes (Figure 4B).
Fetal Keratinocytes and Fetal Fibroblasts Are Able
to Suppress T Cell Proliferation
As T cell activation is one of the early, key events that may
initiate allograft rejection, we asked whether fetal kerati-
nocytes and fetal fibroblasts can activate T cells in cocul-
ture conditions. Neither adult nor fetal cells (keratinocytes
and fibroblasts) induced T cell proliferation (Figures 5A
and 6A). When adult keratinocytes were added into a
CD3/28 bead-induced T cell proliferation assay, theyell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Authors 327
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Figure 3. Fetal Keratinocytes Have a Higher Proliferation Potential than Adult Keratinocytes
(A) Proliferation index (PI) in fetal and adult epidermis. The PI was defined as the number of Ki67-positive cells divided by the total
number of cells at the basal layer 3 100%. Data are represented as mean ± SEM of n biological replicates.
(B) Comparison of the proliferation rates of fetal keratinocytes (17, 19, and 22 weeks) and adult keratinocytes. Data were generated by
counting the number of cells after each passage, subcultured at 70%–80% confluence.
(legend continued on next page)
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Fetal Keratinocytes for Skin Reconstructionwere found to enhance T cell proliferation. In contrast,
high doses of fetal keratinocytes were able to suppress
T cell proliferation in the same assay, suggesting that
these cells have some innate ability to modulate the
immune function of T cells in a dose-dependent manner
(Figures 5B and 5C). The immunosuppressive ability
was more prominent in fetal than adult fibroblasts, with
the suppression increasing in a dose-dependent manner
(Figure 6B).
Cultured Human Fetal Keratinocytes and Fetal
Fibroblasts Can Be Successfully Engrafted with Stable
Human-to-Mouse Skin Regeneration
When tested in an organotypic culture system, fetal kerati-
nocytes were able to generate a multilayered epithelial
structure with suprabasal expression of K10, which is
typical of normal epidermal differentiation (Figures 7A
and S6). Therefore, we grafted fetal keratinocyte-based
skin mimetic constructs onto SCID mice, using a previ-
ously describedmethod (Llames et al., 2004) with somemi-
normodifications (see Experimental Procedures), to further
challenge their ability to differentiate. Successful grafting
was confirmed at 8 weeks posttransplantation. The grafts
showed histological structure similar to mature human
skin, with five to seven epidermal layers and a cornified
layer, as well as good seamless integration between graft
and host tissues (Figures 7B, 7C, and S7). Staining with
human-specific antibodies to nucleus LP4N (Figure 7D;
Jeppe-Jensen et al., 1993), K10 (Figure 7E; Leigh et al.,
1993), involucrin (Figure 7F; Llames et al., 2004), and
vimentin (Figure 7G; Bohn et al., 1992) demonstrated the
persistence of human cells in the full thickness of the graft.
alpha-Smooth muscle actin (a-SMA) was expressed in the
dermis of the regenerated skin at 7 days and 14 days post-
grafting, confirming the expected presence of myofibro-
blasts (Figures 7H and 7I) associated with a wound-healing
state. By 8 weeks postgrafting, the myofibroblasts had
disappeared, reflecting the fully healed state of the skin
graft, and a-SMA staining was limited to blood vessels in
the regenerated skin (Figure 7J). Fetal fibroblasts were also(C) Population doubling (pd) times are derived from each exponentia
(see Figure S5). Fetal (14, 16, 19, and 22 weeks) and adult keratinocy
was monitored over a period of 1 week. Data are represented as mean
(D) Mean telomere restriction fragment (TRF) length of fetal (14 week
was digested with Hinf I and Rsa I, and then separated on a 0.9% ag
probed with a Dig-labeled telomere probe (TTAGGG), and detected v
comparing the location of the TRF on the blot relative to a molecular w
keratinocytes. In both adult and fetal keratinocytes, telomeres short
(E) Comparison of colony-forming activity between cultured fetal (1
efficiency (CFE) was defined as the percentage of colonies formed o
of >1 mm2. After 14 days, culture was arrested and the colonies were
than adult keratinocytes. Data are represented as mean ± SD of three
Stem Cable to successfully integrate into the grafts when adult
keratinocytes were used (Figures 7K–7M).DISCUSSION
We report here the isolation and characterization of fetal
keratinocytes derived from second-trimester fetuses. Fetal
keratinocytes were found to be more proliferative and clo-
nogenic, and to have longer telomeres and lower expres-
sion of MHC proteins than adult keratinocytes. We also
show that fetal keratinocytes are capable of differentiating
in organotypical cultures and can be successfully grafted in
a well-described mouse model. These findings suggest that
fetal skin cells have significant potential as an allogeneic
source of cells for life-saving culture-generated grafts. The
work presented here has implications for a next generation
of cost-effective, user-friendly, bioengineered skin con-
structs based on nonanimal products. The possibility of
‘‘off-the-shelf’’ availability is important, especially in cases
where treatmentmust be carried out early and at very short
notice, such as massive burn wounds.
Human fetal dorsal skin, from which the fetal keratino-
cytes were cultured for this study, was analyzed histologi-
cally to correlate morphologic changes of the skin to
biochemical changes in structural proteins during develop-
ment. K18, which along with K8 is typical of simple
epithelia and early embryonic stages (Moll et al., 1982),
and K19, which is expressed in adult mixed epithelial re-
gions and possibly is a stem cell niche indicator (Stasiak
et al., 1989), were still expressed in the basal epidermal
layer and periderm of fetal skin up until 22 weeks. K17,
which is typically expressed by ‘‘activated’’ keratinocytes,
was present in fetal epidermis but reduced with increasing
age. If fetal cells are ultimately to be used for clinical
applications, quality-control measures will be needed to
ensure that the cells being propagated retain their defined
state. Thus, it is significant that the fetal phenotype persists
in tissue culture, as shown by the retention of fetal
keratin expression in culture. Fetal keratinocyte culturesl phase of the growth curves monitored by a real-time cell analyzer
tes were plated in 96-well plates at 2,500 cells per well. Cell growth
± SD of n biological replicates. ****p < 0.0001.
s) and adult keratinocytes. DNA (2 mg) prepared from keratinocytes
arose gel by gel electrophoresis. It was then transferred to nylon,
ia chemiluminescence. The average TRF length was determined by
eight standard. Fetal keratinocytes have longer telomeres than adult
en with increasing passage number.
7, 19, and 22 weeks) and adult keratinocytes. The colony-forming
ver the number of cells seeded. A colony was defined as a cluster
stained with Rhodamine B. Fetal keratinocytes form more colonies
technical replicates.
ell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Authors 329
Figure 4. Expression of MHC Markers on Fetal and Adult Skin
(A) Fetal skin was observed to express lower levels of MHC molecules than adult skin. Scale bar, 100 mm.
(B) Flow-cytometric analysis for MHC I and MHC II was performed on cultured fetal (16 and 22 weeks) and adult keratinocytes. Purple
tracings represent the stained population, whereas red tracings set the background reference with an isotype-matched antibody. Positive
staining (%) was defined by a gate that included 3% of the background population.
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parts by expression of K18 and K19.
We have shown that fetal keratinocytes can be stably and
successfully cultured in vitro while maintaining their
normal phenotype and karyotype. No slowing of growth
was observed until cells were beyond 20 pds, about twice
as many cell divisions as observed for similar adult cells.
This significantly higher proliferative potential suggests
that fetal cells can provide a long-lived (and thus more
economical and more accessible to a greater number of
patients) cell source for tissue-regeneration applications.330 Stem Cell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The AutThis will facilitate exhaustive characterization of a single
fetal keratinocyte bank prior to clinical use. By using the
isolation and culture techniques described here, one can
induce a 4 cm2 sample of fetal skin to generate sufficient
cells to expand to an area of 16 m2 within 1 week of recov-
ering live cells from a frozen cell bank (Figure S5B). Here, we
cryopreserved cells using a progressive freezing method
and achieved a recovery of >80% even after 3 years of
liquid nitrogen storage, showing that these cells are
robust in tissue culture. We have achieved this efficiency
using serum-free culture without mouse-derived fibroblasthors
Stem Cell Reports
Fetal Keratinocytes for Skin Reconstructionfeeder cells; therefore, the process should be easily and
quickly adapted to meet GMP culture requirements. With
this yield and efficiency, additional steps to enrich for
stem cells may be unnecessary—anything that reduces
handling will increase cell viability and thus further in-
crease cell yield.
In spite of the developmental immaturity of the starting
material, second-trimester fetal keratinocytes are clearly
capable of achieving fundamentally normal adult-type dif-
ferentiation in vitro, as they can form a stratified epidermal
structure in an organotypical culture system that expresses
major structural proteins of adult epidermis. Proof of prin-
ciple was established in a preclinical human-to-mouse
model using immune-deficient mice (Del Rio et al., 2002)
optimized for grafting cultured human fetal keratinocytes
and fibroblasts. The successful engraftment and stable
skin regeneration achieved using cultured fetal skin cells
show that these cells can generate mature, differentiated
epidermis in vivo.
The biggest obstacle to skin grafting using anything
other than the patient’s own cells is immune rejection.
The data presented here reveal low MHC I expression
and no MHC II expression in the fetal skin cells. The fetal
cells were also shown to elicit no proliferative response in
naive T cells. Coculture with fetal keratinocytes or fetal
fibroblasts even led to suppression of T cell proliferation.
Thismay be due to production of factors with immunosup-
pressive activity (Kehrl et al., 1986; Lu´dvı´ksson et al., 2000;
Taylor et al., 2006) or other mechanisms that operate in
the state of mutual immune tolerance that exists between
the fetus and mother during pregnancy (Munn et al.,
1998; Meisel et al., 2004; Hunt et al., 2005). The effect of
fetal skin cells on regulatory T cells (Treg), which are
capable of modulating tolerance in the immune response
(Sakaguchi et al., 2001), may also play a role. In a previous
study, fetal liver mesenchymal stem cells were shown to
exhibit various levels of inhibitory immune effects (Go¨th-
erstro¨m et al., 2004). In a related study, Zuliani et al.
(2013) recently reported evidence of suppression of peri-
pheral blood mononuclear cell (PBMC) proliferation in a
sample of fetal keratinocytes, although theymade no com-
parison with adult cultures. These authors suggested a role
for indoleamine 2,3 dioxygenase (IDO) in the immunosup-
pressive effects. The in vitro data presented here suggest
that fetal keratinocytes may have an ‘‘immunological
advantage’’ that could be of significant benefit in future
clinical applications of these cells.
Although the present study focuses predominantly on
keratinocytes, it has been known for many years that fibro-
blasts play an important role in wound healing and in
remodeling the extracellular matrix. Thus, an ideal bio-
engineered graft will always need to incorporate fibroblasts
as well as keratinocytes. The combination of keratinocytesStem Cand fibroblasts with a keratinocyte/fibroblast ratio of 1:9
in a spray device was shown clinically to be very effective
in promoting wound closure (Goedkoop et al., 2010;
Kirsner et al., 2012). However, the use of such growth-
arrested cells still requires time to stimulate wound
coverage, whereas keratinocytes and fibroblasts grown in
a fibrin scaffold can be grafted instantly. Here, we have
shown that fetal cells in such a combination grow well
for at least 8 weeks in a human-to-mouse skin graft, sug-
gesting that they are a viable option for covering open
wounds.
The improved method of preparing fibrin gels directly
from whole plasma will be useful for constructing bio-
engineered skin equivalents to provide a more cost-
effective and clinically suitable product. Fetal cells have
also been shown to adapt well to various biocompatible
materials with high survival rates (Montjovent et al.,
2005; De Buys Roessingh et al., 2006), favoring their use
in tissue engineering. De Buys Roessingh et al. (2006)
reported that fetal fibroblasts are also resistant to various
environmental stresses and low oxygen conditions, sug-
gesting that they are likely to survive when grafted into
hostile wound environments.
There is much discussion about the potential of induced
pluripotent stem cells (iPSCs) as an autologous cell source
to generate large numbers of tissue cells for therapeutic
applications, including the generation of keratinocytes
(Guenou et al., 2009). When compared with the handling
methods required for iPSCs and embryonic and mesen-
chymal stem cells, the isolation and cell-culture procedures
used for fetal skin cells are technically less demanding.
Expansion and maintenance of iPSCs in an undifferenti-
ated state and during subsequent reprogramming require
the addition of many specific growth factors, presenting a
financial obstacle against upscaling of stem cell cultures
for clinical applications. Unlike stem cells, fetal keratino-
cytes are already programmed for efficient, full epidermal
differentiation, and also have high expansion potential
and low immunogenicity.
Although it is speculative at this point, another possible
benefit of using immature cells such as those described
here for grafting is that it may be possible to reinitiate
appendage formation from fetal cells. The absence of
appendages such as hair follicles and sweat glands is one
of the most difficult consequences of large-scale grafting.
Holbrook et al. (1993) and Holbrook and Minami (1991)
reported that fetal skin tissue from a critical window of
time (9–12 weeks gestation) could initiate follicle morpho-
genesis in vitro. In addition, primary cultures of mouse
fetal and neonatal skin cells containing both epidermal
and dermal cells will reform skin, complete with hair
follicles, if transplanted into subcutaneous sites in the
mouse (Yuspa et al., 1970; Worst et al., 1982). The factorsell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Authors 331
(legend on next page)
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Figure 6. Fetal Fibroblasts Suppress
CD3/28 Bead-Induced T Cell Proliferation
(A) Proliferation of T cells after 8 days of
incubation with cultured fetal (15 weeks)
and adult fibroblasts. CD4 T cells were
labeled with CFSE and cocultured with fetal
and adult fibroblasts. Blue tracings repre-
sent unstimulated T cells (undivided) that
remained CFSEbright. Red tracings represent
proliferating T cells (divided) stimulated
with CD3/28 beads that were CFSEdim in the
presence of 1 3 105 fibroblasts.
(B) MFI of CFSE. Lower MFI values indicate
more proliferation of cells due to the dilu-
tion of CFSE as the cells divide. Left: MFI of
CFSE when cocultured with fetal fibroblasts
(15, 17, and 19 weeks). Right: MFI of CFSE
when cocultured with adult fibroblasts. In
all experiments, three adult and three fetal
samples were used. Data are represented as
mean ± SD of three biological replicates
and using Dunnett’s post hoc analysis. *p <
0.05, **p < 0.01, ***p < 0.001.
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Fetal Keratinocytes for Skin Reconstructionthat control sweat-gland development are even less under-
stood, but recent publications have begun to address the
nature of sweat-gland stem cells (Lu et al., 2012) and the
interaction between progenitor cells and extracellular ma-
trix in generating sebaceous glands (Horsley et al., 2006).
Human-to-mouse culture grafts using cultured fetal cells
as described here will be useful for studies on wound heal-
ing and diseases. Wound healing in adults usually results
in scarring, which can cause functional restrictions in
movement as well as negative physical and psychological
effects on the patient. Formation of hypertrophic scars
and keloids is also a burden and is difficult to treat medi-
cally. The developing fetus has a remarkable ability to
heal skin wounds by regenerating normal epidermis and
dermis with restoration of skin architecture, strength, and
function in the absence of any scar formation (Bullard
et al., 2003).Figure 5. Fetal Keratinocytes Suppress T Cell Proliferation at Hig
Proliferation of T cells after 8 days of incubation with cultured kerati
(A) PBMCs labeled with CFSE were cocultivated with keratinocytes for 8
(undivided) remained CFSEbright. Adult and fetal keratinocytes (19 we
(B) Proliferation of stimulated T cells after 8 days of incubation with
stained with CFSE, stimulated with CD3/28 beads, and cocultured wit
(C) Mean fluorescence intensity (MFI) of CFSE. Lower MFI values ind
cells divide. Left: MFI of CFSE when cocultured with fetal keratinocyte
adult keratinocytes. Data are represented as mean ± SD of three biol
**p < 0.01, ***p < 0.001.
Stem CAlthough there is strong clinical support for developing
cellular therapies, and the use of such therapies is already
reaching clinical translation (Go¨therstro¨m et al., 2014),
ethical issues associated with the collection and use of
fetal tissue for research and therapy still remain. Concerned
political and religious groups have lobbied against funding
for research using fetal tissues that have been obtained
from clinically indicated termination of pregnancies,
restricting progress in the field. Donation of fetal skin is
considered as an organ donation by law in Singapore and
most other countries, but this process is highly regulated
under strict guidelines and human tissue transplanta-
tion laws, including ethics committee approval of the
procedure.
The future of fetal cell therapy is likely to be beset with
numerous ethical issues, not the least of which is the
reluctance of some patients to receive grafts from fetalh Numbers
nocytes.
days. Proliferating T cells (divided) were CFSEdim and resting T cells
eks) did not cause T cells to proliferate.
cultured fetal (19 weeks) and adult keratinocytes. CD4 T cells were
h keratinocytes for 8 days before flow-cytometry analysis.
icate more proliferation of cells due to the dilution of CFSE as the
s (17, 19, and 22 weeks). Right: MFI of CFSE when cocultured with
ogical replicates and using Dunnett’s post hoc analysis. *p < 0.05,
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Fetal Keratinocytes for Skin Reconstructioncells. This issue will likely be less acute in emergency life-
saving situations such as extensive burns, which would
probably be the first context in which fetal grafts would
be tested, but will have to be dealt with sensitively. All
human tissue is precious. As we begin to understand
much more about the mechanisms behind skin regenera-
tion, a new approach to grafting is timely, and this may
well be the most significant phase in the evolution of
skin reconstruction.EXPERIMENTAL PROCEDURES
Skin Biopsies
Human fetal tissues were obtained from National University
Hospital, Singapore, with approval from the local institutional
review board (IRB). Women undergoing clinically indicated termi-
nation of pregnancy gave written informed consent for the use of
fetal tissue for this research. Fetal skin samples were collected from
the back after completion of termination, with gestational ages
ranging between 13 and 23 weeks of amenorrhoea (n = 60 sam-
ples). Human adult skin samples were obtained from discarded
surgicalmaterial fromhealthy donors with their informed consent
and with approval from the local IRB. Skin samples were fixed in
10% neutral buffered formalin or snap-frozen in liquid nitrogen
for subsequent processing for histochemistry.Histological and Immunostaining Analysis
Formalin-fixed skin samples were processed for paraffin wax
embedding. Endogenous peroxidase activity in sections was
quenched by incubation with 1% H2O2 for 30 min and antigen
access was recovered by heating in citrate buffer pH 6. Sections
were incubated with primary antibodies for 90 min at room tem-
perature (Table S2) after blocking in 10% goat serum. Sections
were washed in water and then incubated in secondary antibody
using the EnVision system (Dako) for 30min at room temperature.
Peroxidase activity was detected with diaminobenzidine tetrahy-Figure 7. Fetal Keratinocytes Can Stratify in In Vitro Skin Equi
Human-to-Mouse Skin Regeneration
(A) Hematoxylin and eosin staining of skin equivalents of culture
fibroblast-embedded collagen gel and cultured in a submerged condi
air-liquid interface for 14 days. Expression of K10 in suprabasal layers d
100 mm. See also Figure S6.
(B) Histological appearance of culture-generated human fetal skin on
(C and D) Immunofluorescence staining with the antibody LP4N, whi
stained and the nuclei of mouse epidermis were unstained.
(E–G) Human-specific keratin 10 (K10), involucrin (INV), and vimentin
Antibody staining shows normal stratification in grafted skin 8 week
(H–J) Immunostaining of a-SMA at the junction of regenerated human
1 week postgrafting, indicating the presence of myofibroblasts. At 8
the regenerated skin, but myofibroblasts had disappeared by that tim
(K–M) Human-specific K10, INV, and VIM immunostaining at the jun
adult keratinocytes. Scale bar, 100 mm.
See also Figure S7.
Stem Cdrochloride (DAB) substrate (Dako). Sections were counterstained
with hematoxylin.
For immunofluorescence, frozen sections or cells grown on ibi-
Treat chambers (Ibidi) were fixed in methanol/acetone (1:1) at
–20C for 10 min and blocked in 10% goat serum as above. Sec-
tions or cells were incubated with primary antibodies for 60 min
(Table S2), followed by incubation with secondary antibody
coupled to Alexa Fluor 488 (Molecular Probes; Life Technologies)
and counterstained with DAPI.Isolation and Culture of Epidermal Keratinocytes
and Dermal Fibroblasts
Fetal skin biopsies were washed in 43 antibiotic/antimycotic
solution (Sigma-Aldrich), cut into small pieces, and soaked in
0.125% trypsin at 4C overnight. Specimens were dissociated
into single-cell suspensions and filtered using a cell strainer (BD
Biosciences). Cells were cultured in DermaLife K serum-free
keratinocyte culture media (Lifeline Cell Technology) to establish
keratinocyte cultures. For fetal skin at <18 weeks gestation, a
0.1% gelatin solution (StemCell Technologies) was used to
coat culture flasks to improve cell attachment for keratinocytes.
Fibroblast cultures were established using Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% serum. For
keratinocyte cultures, contaminating fibroblasts were removed
by treatment with 0.02% EDTA (Sigma-Aldrich) for 5 min
(Figure S4).
To isolate adult keratinocytes, adult skin was soaked in Dispase
(Roche Applied Science) at 4C overnight, followed by separation
of the epidermis from the dermis. The epidermis was incubated
with 0.125% trypsin for 20 min and the cell suspension was
centrifuged and seeded on tissue culture flasks. Adult fibroblasts
were isolated by collecting cells growing out from minced tissue
organoids in culture.Organotypic Culture
Adult fibroblasts embedded in rat-tail collagen I (BD Biosciences)
were prepared and placed into a hanging-cell culture insert (1 mmvalent Models and Can Be Engrafted Successfully with Stable
d keratinocytes. Fetal and adult keratinocytes were seeded on a
tion before initiating differentiation of the epidermal layer at the
emonstrates that fetal keratinocytes can stratify in vitro. Scale bar,
the back of a SCID mouse 3 weeks postgrafting.
ch is specific for human cells. The nuclei of human epidermis were
(VIM) immunostaining at the junction of regenerated human skin.
s postgrafting.
skin. a-SMA was expressed in the dermis of the regenerated skin at
weeks postgrafting, a-SMA marked the presence of blood vessels in
e.
ction of regenerated human skin grafted with fetal fibroblasts and
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Fetal Keratinocytes for Skin Reconstructionpore size; Merck Millipore). Fetal keratinocytes (1 3 105 cells)
were seeded on top of collagen gels and cultured in a submerged
state for 7 days and then at the air-liquid interface for 14 days.
Keratinocytes in the submerged state were maintained with
serum-free medium, and fibroblasts in collagen gels were main-
tained with growth medium consisting of a mixture of three
parts DMEM to one part Ham’s nutrient mixture F12 medium
supplemented with 10% fetal bovine serum (FBS), 5 mg/ml insu-
lin, 0.4 mg/ml hydrocortisone, 5 mg/ml transferrin, 1.8 3 104
M adenine, 10 ng/ml epidermal growth factor (EGF), and 2 3
1011 M triiodothyronine. At the air-liquid interface, EGF
and serum were removed from the medium. Samples were fixed
in 10% neutral buffered formalin and embedded in paraffin for
histology (Figure S6).T Cell Proliferation Assay
T cell proliferation was evaluated by flow cytometry after PBMCs
labeled with carboxyfluorescein succinimidyl ester (CFSE) had
been incubated for 8 days with cultured keratinocytes or
fibroblasts. The cell-surface dye CFSE is retained on the cells but
gradually dilutes as cells divide and share the remaining dye
between the daughter cells, resulting in lower fluorescence
intensity in a proliferating cell population. As a positive control,
beads coated with anti-CD3 and anti-CD28 were used to
stimulate T cells to divide in vitro. For the immunomodulatory
assay, isolated CD4+ T cells were stained with CFSE prior to
stimulation with CD3/28 beads, and 200,000 cells were cocul-
tured with keratinocytes (P5) or fibroblasts (P2) with different
seeding densities. Lymphocyte cell division was assessed after
8 days.Plasma-Based Skin-Equivalent Transplants
A dermal-equivalent construct was generated from pig blood
plasma (Equitech-Bio) using methods modified and optimized
from a published protocol (Llames et al., 2004, 2006). Fibroblasts
were resuspended at a concentration of 1 3 106 cells/ml before
preparation of the fibrin gel. Then, 3 ml of mixed plasma, fibro-
blasts, and thrombin (6 NIH U/ml) was added into each culture
insert (BD Biosciences). The mixture was incubated at 37C
for 2 hr to allow thrombin-cleaved plasma fibrinogen to form a
fibrin gel before addition of medium. The following day, 5 3 105
keratinocytes in 200 ml suspension were seeded on top of the gel
and then cultured in a submerged state until the keratinocytes
reached confluence.
Human-to-mouse grafting was performed as described previ-
ously (Del Rio et al., 2002) using SCID mice, with minor modifi-
cations. A 3 cm 3 3 cm area of mouse skin, comparable in size to
the graft, was surgically excised and devitalized by freezing (by
immersion in liquid nitrogen for 2 min) and heating (in an
80C water bath for 2 min) cycles for three times. The devitalized
skin flap was fixed in place with a continuous running stitch
around half of the flap to form a pocket. The gel with fibroblasts
and confluent keratinocytes was carefully lifted and placed inside
the pocket, which was then closed by a continuous suture. No
further bandaging was required. The mouse was placed in a clean
and warm environment to recover. At scheduled time points of
the study, mice were euthanized and skin tissue was collected336 Stem Cell Reports j Vol. 3 j 324–338 j August 12, 2014 j ª2014 The Autfor histology. All procedures were approved by the local IACUC,
and animals were cared for in accordance with institutional
guidelines.
Statistical Analysis
Data are presented as the mean and SD or SEM where appropriate.
Data analysis was performed by one-way ANOVA followed by
post hoc Dunnett’s test for multiple comparisons of at least
three groups or by unpaired Student’s t test for two groups using
Prism 5.0 (Graphpad Software); p values < 0.05 were considered
statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
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